A method for screening drugs against the liver stages of malaria using Plasmodium gallinaceum and Aedes mosquitos
Braz. j. med. biol. res
; 25(3): 247-55, 1992. tab
Article
in English
| LILACS
| ID: lil-109025
Responsible library:
BR26.1
RESUMO
The radical cure of human malaria caused by Plasmodium vivax requires two drugs, i.e., a blood schizontocide such as chloroquine to clear the circulating parasites, and primaquine aimed at the liver stages (hypnozoites) responsible for the late relapses of this parasite. Primaquine is unique as a radical curative drug but is highly toxic. The only useful model currently available
Search on Google
Collection:
International databases
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
/
Neglected Diseases
Health problem:
Goal 5: Medicines, vaccines and health technologies
/
Target 3.3: End transmission of communicable diseases
/
Malaria
/
Neglected Diseases
Database:
LILACS
Main subject:
Primaquine
/
Plasmodium gallinaceum
/
Drug Evaluation, Preclinical
/
Gametogenesis
/
Malaria
Type of study:
Diagnostic study
/
Prognostic study
/
Screening study
Language:
English
Journal:
Braz. j. med. biol. res
Journal subject:
Biology
/
Medicine
Year:
1992
Document type:
Article